SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $30.80 million. The enterprise value is -$7.32 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 38.98 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 38.98M |
| Shares Outstanding | 38.98M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 24.99% |
| Float | 34.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 158.00 |
| PS Ratio | 14.66 |
| Forward PS | 0.41 |
| PB Ratio | 0.61 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.83, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.83 |
| Quick Ratio | 5.62 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.89 |
Financial Efficiency
Return on equity (ROE) is -43.47% and return on invested capital (ROIC) is -31.80%.
| Return on Equity (ROE) | -43.47% |
| Return on Assets (ROA) | -24.32% |
| Return on Invested Capital (ROIC) | -31.80% |
| Return on Capital Employed (ROCE) | -61.43% |
| Revenue Per Employee | $93,929 |
| Profits Per Employee | -$967,500 |
| Employee Count | 28 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -380,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.04% in the last 52 weeks. The beta is 1.65, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -65.04% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 33.87 |
| Average Volume (20 Days) | 110,549 |
Short Selling Information
The latest short interest is 641,209, so 1.64% of the outstanding shares have been sold short.
| Short Interest | 641,209 |
| Short Previous Month | 691,453 |
| Short % of Shares Out | 1.64% |
| Short % of Float | 1.84% |
| Short Ratio (days to cover) | 5.92 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $2.63 million and -$27.09 million in losses. Loss per share was -$0.56.
| Revenue | 2.63M |
| Gross Profit | 2.63M |
| Operating Income | -36.22M |
| Pretax Income | -34.72M |
| Net Income | -27.09M |
| EBITDA | n/a |
| EBIT | -36.22M |
| Loss Per Share | -$0.56 |
Full Income StatementBalance Sheet
The company has $40.61 million in cash and $2.49 million in debt, giving a net cash position of $38.12 million or $0.98 per share.
| Cash & Cash Equivalents | 40.61M |
| Total Debt | 2.49M |
| Net Cash | 38.12M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 50.53M |
| Book Value Per Share | 1.30 |
| Working Capital | 43.26M |
Full Balance SheetCash Flow
| Operating Cash Flow | -27.47M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.47M |
| FCF Per Share | -$0.70 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,377.15% |
| Pretax Margin | -1,044.49% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |